Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia: a Prospective, Non-interventional, Multi-centric, Clinical Performance Study

NCT05613322 is registered in ClinicalTrials.gov with Resistell AG as lead sponsor.

NCT NCT05613322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05613322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia: a Prospective, Non-interventional, Multi-centric, Clinical Performance Study
Lead sponsor
Resistell AG
Phase
Observational
Overall status
Terminated
Start date
January 18, 2023
Completion date
September 5, 2024
Enrollment
246 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia sepsis